Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Effects of crosslinking agents on properties of starch-based intelligent labels for food freshness detection.
Hydroxymethylglutaryl CoA Reductases
Intrathecal gene therapy for neurologic disease in humans.
Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Intrathecal gene therapy for neurologic disease in humans.
Flotte TR. Intrathecal gene therapy for neurologic disease in humans. Mol Ther. 2024 May 01; 32(5):1185-1186.
View in:
PubMed
subject areas
Animals
Genetic Therapy
Genetic Vectors
Humans
Injections, Spinal
Nervous System Diseases
authors with profiles
Terence R Flotte MD